Low-density lipoprotein metabolism in the nephrotic syndrome

Metabolism. 1990 Feb;39(2):187-92. doi: 10.1016/0026-0495(90)90074-m.

Abstract

Hyperlipidemia is a consistent feature of the nephrotic syndrome. In this study, low-density lipoprotein (LDL) metabolism has been investigated in nine patients with nephrotic syndrome and varying degrees of proteinuria. In subjects with moderate proteinuria (less than 10 g/d), total plasma cholesterol values were elevated to approximately 160% of normal due mainly to an increase in circulating LDL cholesterol. Metabolic studies showed that a defect in LDL clearance via the receptor pathway was responsible for its accumulation. The total amount of LDL apolipoprotein catabolized by this mechanism was only 55% of the value seen in controls; 60% more LDL was channelled into alternative, receptor-independent, catabolic pathways. Heavier proteinuria was associated with substantial increases in plasma triglyceride and very-low-density lipoprotein (VLDL) levels. The defect in LDL catabolism was aggravated by oversynthesis of the lipoprotein, which expanded the plasma LDL pool to 250% of normal. These observations indicate that the hyperlipidemia of the nephrotic syndrome is multifactorial in origin. The altered catabolism of LDL may be important in predisposing these subjects to premature atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cardiovascular Diseases / etiology
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Female
  • Humans
  • Hyperlipidemias / etiology
  • Hyperlipidemias / metabolism
  • Kinetics
  • Lipoproteins, LDL / biosynthesis
  • Lipoproteins, LDL / metabolism*
  • Lipoproteins, VLDL / metabolism
  • Liver / metabolism
  • Male
  • Middle Aged
  • Nephrotic Syndrome / complications
  • Nephrotic Syndrome / metabolism*
  • Proteinuria / blood
  • Proteinuria / urine
  • Risk
  • Triglycerides / blood

Substances

  • Cholesterol, LDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Triglycerides
  • Cholesterol